Compare ALGT & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALGT | NBTX |
|---|---|---|
| Founded | 1997 | 2003 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2006 | 2020 |
| Metric | ALGT | NBTX |
|---|---|---|
| Price | $82.79 | $21.20 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 1 |
| Target Price | ★ $75.10 | $8.00 |
| AVG Volume (30 Days) | ★ 309.5K | 52.1K |
| Earning Date | 11-04-2025 | 09-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,578,095,000.00 | $11,930,711.00 |
| Revenue This Year | $5.43 | N/A |
| Revenue Next Year | $2.15 | $136.64 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 3.29 | N/A |
| 52 Week Low | $39.80 | $2.76 |
| 52 Week High | $107.57 | $30.35 |
| Indicator | ALGT | NBTX |
|---|---|---|
| Relative Strength Index (RSI) | 69.97 | 52.51 |
| Support Level | $73.70 | $20.05 |
| Resistance Level | $78.27 | $22.05 |
| Average True Range (ATR) | 4.11 | 1.04 |
| MACD | 1.39 | -0.01 |
| Stochastic Oscillator | 96.28 | 48.83 |
Allegiant Travel Co is a leisure travel company focused on providing travel and leisure services and products to residents of under-served cities in the United States. It operates a low-cost, low utilization passenger airline marketed to leisure travelers in under-served cities, allowing it to sell air transportation both on a stand-alone basis and bundled with the sale of air-related and third-party services and products. In addition, it provides air transportation under fixed-fee flight arrangements. In connection with its leisure travel focus, the company has opened Sunseeker Resort Charlotte Harbor, equipped with several guestrooms and food and beverage outlets. The company's operating segments are the Airline, which generates maximum revenue, and Sunseeker Resort.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.